158 related articles for article (PubMed ID: 30697874)
1. Tumor necrosis factor receptor modulator spermatogenesis-associated protein 2 is a novel predictor of outcome in ovarian cancer.
Wieser V; Tsibulak I; Degasper C; Welponer H; Leitner K; Parson W; Zeimet AG; Marth C; Fiegl H
Cancer Sci; 2019 Mar; 110(3):1117-1126. PubMed ID: 30697874
[TBL] [Abstract][Full Text] [Related]
2. TNFα signalling predicts poor prognosis of patients with endometrial cancer.
Wieser V; Abdel Azim S; Sprung S; Knoll K; Kögl J; Hackl H; Marth C; Zeimet AG; Fiegl H
Carcinogenesis; 2020 Aug; 41(8):1065-1073. PubMed ID: 32301486
[TBL] [Abstract][Full Text] [Related]
3. SPATA2 links CYLD to the TNF-α receptor signaling complex and modulates the receptor signaling outcomes.
Wagner SA; Satpathy S; Beli P; Choudhary C
EMBO J; 2016 Sep; 35(17):1868-84. PubMed ID: 27307491
[TBL] [Abstract][Full Text] [Related]
4. The role of SPATA2 in TNF signaling, cancer, and spermatogenesis.
Masola V; Greco N; Tozzo P; Caenazzo L; Onisto M
Cell Death Dis; 2022 Nov; 13(11):977. PubMed ID: 36402749
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid induces tumor necrosis factor-alpha to regulate a pro-inflammatory cytokine network in ovarian cancer.
Wang W; Wu J; Mukherjee A; He T; Wang XY; Ma Y; Fang X
FASEB J; 2020 Oct; 34(10):13935-13948. PubMed ID: 32851734
[TBL] [Abstract][Full Text] [Related]
6. Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
Mustea A; Pirvulescu C; Könsgen D; Braicu EI; Yuan S; Sun P; Lichtenegger W; Sehouli J
Cytokine; 2008 Apr; 42(1):77-84. PubMed ID: 18329282
[TBL] [Abstract][Full Text] [Related]
7. TNF-α expression, risk factors, and inflammatory exposures in ovarian cancer: evidence for an inflammatory pathway of ovarian carcinogenesis?
Gupta M; Babic A; Beck AH; Terry K
Hum Pathol; 2016 Aug; 54():82-91. PubMed ID: 27068525
[TBL] [Abstract][Full Text] [Related]
8. SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death.
Schlicher L; Wissler M; Preiss F; Brauns-Schubert P; Jakob C; Dumit V; Borner C; Dengjel J; Maurer U
EMBO Rep; 2016 Oct; 17(10):1485-1497. PubMed ID: 27458237
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization and expression profiling of 17-beta-hydroxysteroid dehydrogenase 2 and spermatogenesis associated protein 2 genes in endangered catfish,
Agarwal D; Gireesh-Babu P; Pavan-Kumar A; Koringa P; Joshi CG; Gora A; Bhat IA; Chaudhari A
Anim Biotechnol; 2020 Apr; 31(2):93-106. PubMed ID: 30570357
[TBL] [Abstract][Full Text] [Related]
10. The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells.
Kulbe H; Hagemann T; Szlosarek PW; Balkwill FR; Wilson JL
Cancer Res; 2005 Nov; 65(22):10355-62. PubMed ID: 16288025
[TBL] [Abstract][Full Text] [Related]
11. Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis.
Tsao TC; Hong Jh; Li LF; Hsieh MJ; Liao SK; Chang KS
Chest; 2000 Jan; 117(1):103-9. PubMed ID: 10631206
[TBL] [Abstract][Full Text] [Related]
12. Host-tumor interaction in ovarian cancer. Spontaneous release of tumor necrosis factor and interleukin-1 inhibitors by purified cell populations from human ovarian carcinoma in vitro.
Burger RA; Grosen EA; Ioli GR; Van Eden ME; Brightbill HD; Gatanaga M; DiSaia PJ; Granger GA; Gatanaga T
Gynecol Oncol; 1994 Nov; 55(2):294-303. PubMed ID: 7959299
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of Ki-67 levels and hormone receptor expression in low-grade serous ovarian carcinoma: an investigation of the Tumor Bank Ovarian Cancer Network.
Sehouli J; Braicu EI; Richter R; Denkert C; Jank P; Jurmeister PS; Kunze CA; Budczies J; Darb-Esfahani S; Schmitt WD; Traut A; Grabowski J; Taube ET; Plett H
Hum Pathol; 2019 Mar; 85():299-308. PubMed ID: 30428389
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide suppressed IL-1beta while enhancing TNF-alpha and IL-10, when cells in whole blood were stimulated with lipopolysaccharide.
Shannon E; Noveck R; Sandoval F; Kamath B
Immunopharmacol Immunotoxicol; 2008; 30(3):447-57. PubMed ID: 18668392
[TBL] [Abstract][Full Text] [Related]
15. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K
Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
[TBL] [Abstract][Full Text] [Related]
16. Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer.
Horak P; Pils D; Haller G; Pribill I; Roessler M; Tomek S; Horvat R; Zeillinger R; Zielinski C; Krainer M
Mol Cancer Res; 2005 Jun; 3(6):335-43. PubMed ID: 15972852
[TBL] [Abstract][Full Text] [Related]
17. Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer.
Kolomeyevskaya N; Eng KH; Khan AN; Grzankowski KS; Singel KL; Moysich K; Segal BH
Gynecol Oncol; 2015 Aug; 138(2):352-7. PubMed ID: 26001328
[TBL] [Abstract][Full Text] [Related]
18. Urinary interleukin-1β levels among gynecological patients.
Woolery KT; Hoffman MS; Kraft J; Nicosia SV; Kumar A; Kruk PA
J Ovarian Res; 2014 Nov; 7():104. PubMed ID: 25403235
[TBL] [Abstract][Full Text] [Related]
19. Soluble TNF-alpha receptor and IL-1 receptor antagonist elevation in BAL in active pulmonary TB.
Tsao TC; Li L; Hsieh M; Liao S; Chang KS
Eur Respir J; 1999 Sep; 14(3):490-5. PubMed ID: 10543265
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha and its receptors in epithelial ovarian cancer.
Dobrzycka B; Terlikowski SJ; Garbowicz M; Niklińska W; Bernaczyk PS; Nikliński J; Kinalski M; Chyczewski L
Folia Histochem Cytobiol; 2009; 47(4):609-13. PubMed ID: 20430728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
